MSH2 and prostate adenocarcinoma: These results described the association of loss of MMR proteins with the high-grade group, although statistically insignificant, which aligns with the study by Guedes et al., in which they found the maximum loss of MSH2 protein in prostatic adenocarcinoma with high Gleason score/grade group [15].